Sigma Healthcare logo
SIG
Health Care Equipment & Services

Sigma Healthcare

Short interest
5.43%
+0.84 pp 30d
as of 8 Oct 2026
Reported shorts
627M
Shares on issue
11.544B

Sigma Healthcare (SIG) Short Interest

Sigma Healthcare (ASX:SIG) had 5.43% of shares reported as short positions as of 8 Oct 2026, representing 627,016,300 shares. Sigma Healthcare operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Price & short interest

About Sigma Healthcare

Sigma Healthcare is a leading Australian retail pharmacy franchisor and full-line pharmaceutical wholesaler and distributor. They support a large retail network of franchised pharmacies, including Chemist Warehouse, Amcal, and Discount Drug Stores. In February 2025, Sigma merged with Chemist Warehouse Group, combining Sigma's distribution infrastructure with Chemist Warehouse's retail expertise.

Company profile →

Sigma Healthcare (ASX:SIG) has 5.43% of its shares on issue reported as short positions as of 8 Oct 2026, or about 627,016,300 shares. Over the past 30 days that figure has risen 0.84 percentage points, and over 90 days it has risen 1.66 percentage points. Its highest recorded short interest was 7.54% in July 2018. SIG is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads SIG today

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

SIG fundamentals

In the year to 30 Jun 2026, Sigma Healthcare (ASX:SIG) recorded revenue of A$10.8B and net profit after tax of A$709.2M. A year earlier it recorded revenue of A$6.0B and net profit after tax of A$529.9M. Year-on-year growth: revenue +80.5% (FY), EPS +21.6% (FY). Net margin 6.5%, return on equity 14.7% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →

Company details

address

Level 6, 2125 Dandenong Road, CLAYTON, VIC, AUSTRALIA, 3168

Connect

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

Be the first to discuss SIG

Start a research thread or post the first pulse update